Saturday, June 06, 2015 7:08:16 PM
To get anyone up to speed on the FDA...They cleared the ActiBand because it was "substantially equivalent" to an approved device, that was in 2002.
Then over the years, as BIEL tried to get other devices cleared for Rx and OTC, the FDA said they were "Not Substantially Equivalent" to any predicate devices. Including apparently, the device the FDA had already approved. They also felt that BIEL's products did not fit into either existing PEMF product codes (IMJ,ILX) because it was not "Short Wave Diathermy" it was considered "Non-Thermal Diathemy". Which literally means "not produced by heat, electrically produced heat". Seriously. That makes sense, right?!?
Despite having a product that is effective and safe, BIEL was stranded essentially, with no path to OTC clearance.
Last year (FEB. 2014) the FDA "on their own accord" wink, wink...proposed a rule change to make a category and pathway to OTC for BIEL and others with similar newly coded "Short Wave Therapy" devices.
If the FDA ever gets around to making it a final rule, this should really correct the current contradicting product codes.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM